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Does the treatment of obstructive sleep apnea syndrome
improve lower urinary tract symptoms?
Öner ODABAŞ, Cavit CEYLAN, Metin YIĞMAN

Aim: To evaluate lower urinary tract symptoms in patients with obstructive sleep apnea syndrome (OSAS) and to
determine if the symptoms improved after treatment for OSAS.
Materials and methods: In all, 145 male patients were diagnosed with OSAS via polysomnography and evaluated for
lower urinary tract symptoms using the International Prostate Symptom Score (IPSS). All of the patients were evaluated
by an ear, nose, and throat (ENT) specialist. Surgery or continuous positive airway pressure treatment was recommended
based on the apnea-hypopnea index (AHI) and ENT examination results. Only 23 of the patients that were available for
follow-up during treatment were included in the study. The IPSS form was administered after treatment and symptom
scores were updated for the 23 patients. The age range of the 23 patients was 26-65 years. The Wilcoxon signed rank,
Kruskal-Wallis, and Spearman rho tests were used to evaluate differences in IPSSs before and after treatment.
Results: After treatment, significant improvement in lower urinary tract symptoms was confirmed statistically based on
the IPSSs of 23 OSAS patients (P < 0.001). The difference in the IPSS before and after treatment was not associated with
the AHI, treatment method, patient age, or body mass index (P > 0.05).
Conclusion: Most of the OSAS patients had lower urinary tract symptoms, and significant improvement in these
symptoms was observed following treatment for OSAS.
Key words: Obstructive sleep apnea syndrome, treatment, lower urinary tract symptoms

Obstruktif uyku apnesinin tedavisi alt üriner semptomları düzeltir mi?
Amaç: Obstruktif uyku apnesi olan hastalarda alt üriner sistem semptomlarının sorgulanması ve apne tedavisi ile
semptomlarda düzelmenin araştırılması.
Yöntem ve gereç: Uyku apnesi yakınmasıyla uyku laboratuarında incelemeye alınan 145 erkek hastada alt üriner sistem
semptomlarının sorgulanması için hastalara IPSS sorgulama formu dolduruldu. Bütün hastalara KBB muayeneleri
yapıldı. Muayene bulgularına ve apne-hipopne indeksine (AHI) göre CPAP veya cerrahi tedavi önerildi. Takip edilebilen
ve tedavi alan 23 hastaya IPSS formu tekrar doldurularak semptom skorlaması yinelendi. Bu hastaların yaşları 26 ile
65 arasında değişmekteydi. Tedavi öncesi ve sonrası skor farklılıklarının değerlendirilmesinde Wilcoxon signed ranks,
Kruskal-Wallis, Spearman rho testleri kullanıldı.
Bulgular: Uyku apnesi olan, tedavi ve takibi yapılabilen 23 hastanın IPSS’inde istatistiksel olarak anlamlı düzelme
saptanmıştır (P < 0,001). Tedavi öncesi ve sonrasında IPSS değişimi ile AHİ, tedavi yöntemi, hasta yaşı ve vücut kitle
indeksi arasında anlamlı bir ilişki saptanmamıştır (P > 0,05)
Sonuç: Uyku apnesi yakınması olan hastaların çoğunda farkında olmaksızın alt üriner sistem semptomları mevcut olup,
apne tedavisi ile bu semptomlarda belirgin düzelme olduğu saptanmıştır.
Anahtar sözcükler: Alt üriner sistem semptomları, tedavi, uyku apnesi
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Introduction
Obstructive sleep apnea syndrome (OSAS) is a
serious health problem involving several body
systems, and it is a result of repetitive respiratory
dysfunction (apnea and hypopnea) due to upper
respiratory tract obstruction (1). OSAS is diagnosed
via polysomnography. Most symptoms of OSAS
are related to interrupted sleep. On the other hand,
urological symptoms are related to sexual and
lower urinary tract system functions. The cause of
decreased libido and sexual dysfunction are not
well understood. A reduction in the testosterone
level, sleep impairment, snoring, respiratory
impairment during sleep, and lack of interest in sex
d d ue to inefficient sleep are among the possible
causes of sexual dysfunction. An increase in effort
for respiration due to apnea and hypopnea, atrial
natriuretic factor secretion due to change in pressure
in the thorax, and rennin-angiotensin system
dysfunction cause nocturia (2).

apnea-hypopnea index (AHI). The AHI is among the
parameters used to diagnose OSAS and its severity, as
follows: AHI 5-14: mild, AHI 15-30: moderate, and
AHI > 30: severe (3).
The IPSS test was readministered to 23 patients
that were available for posttreatment follow-up.
The Wilcoxon signed rank, Kruskal-Wallis, and
Spearman rho tests were used to evaluate pre- and
posttreatment differences.
Results
The age range of the 23 patients that were followed
up with after treatment was 26-65 years. Based on
the AHI, 4 patients had mild OSAS, 5 had moderate
OSAS, and 14 had severe OSAS. The IPSSs in these
23 patients were as follows: mild: n = 10, moderate:
n = 9, and severe: n = 4. Treatment for OSAS was
determined according to disease severity and ENT
examination findings (Figure).

Based on the relationship between OSAS and
lower urinary tract symptoms, the present study
aimed to determine if treatment for OSAS improves
lower urinary tract symptoms. All male patients
diagnosed with OSAS were considered for inclusion
in the study, but only those treated and followed
up with for OSAS were included. The relationship
between lower urinary tract system symptoms and
OSAS before and after treatment was investigated.

Treatment Methods
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Figure. Treatment for OSAS.

Materials and methods
In total, 145 male patients were monitored in the
sleep lab due to complaints of sleep apnea and were
diagnosed with OSAS between January and May
2010. The International Prostate Symptom Score
(IPSS) screening tool was administered to these
patients by a urologist to determine if they had lower
urinary tract symptoms (with 2 additional questions:
the number of daytime urinations and the number
urinations due to sudden urge). All of the patients
had both voiding and filling symptoms. Each patient
was also examined by an ear, nose, and throat (ENT)
specialist. Constant positive air pressure (CPAP),
uvulopalatal flap, and radiofrequency treatment were
suggested according to the severity of disease, which
was determined via physical examination and the

RF
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After treatment, all 23 of the patients had a
significantly improved IPSS as compared to before
treatment (P < 0.001) (Table 1). Posttreatment filling
symptoms only improved in 4 patients and 2 patients’

Table 1. Pre- and posttreatment IPSSs.
Pretreatment score

Posttreatment score

Mean

16

9

Minimum

5

2

Maximum

40

25
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severe OSAS were higher than the scores in those
with mild OSAS and the controls (P < 0.05) (4). They
indicated that hypoxia-related nerve dysfunction
might play a role in the physiopathology of the event.

symptom scores remained the same. The other
patients had improvement in both voiding and filling
symptoms. After treatment, the patients that still had
lower urinary tract symptoms were referred to the
urology outpatient clinic. The means and standard
deviations for patient age, height, weight, and AHI
score are shown in Table 2.

Moriyama et al. reported that the AHI was
higher in male OSAS patients aged <50 years in
the nocturia symptoms group (P = 0.005), but a
statistically significant relationship between the AHI
and nocturia was not observed in the patients aged
>50 years. Moreover, while there was no difference in
IPSSs between the OSAS patients aged <50 years with
and without nocturia, the IPSSs in the OSAS patients
aged >50 years with nocturia were higher than in the
OSAS patients aged >50 years without nocturia (P =
0.001) (5). In the present study, we used a modified
IPSS test that included 2 additional questions,
including irritative symptoms. A large-scale study
by Oztura et al. reported that the prevalence of
nocturia was 52%-76.9% and that it was due to the
severity of sleep dysfunction (8). There are a limited
number of studies on the relationship between
the treatment of sleep dysfunction and urinary
symptoms (10-12). Margel et al. examined nocturia
only in OSAS patients before and during CPAP
treatment and reported that there was statistically
significant improvement (P < 0.001) in response to
CPAP treatment (10). Guielleminault et al. reported
that nasal CPAP treatment reduced the nocturia
and severity of OSAS in oldd patients (11). In the

There was no significant relationship between the
difference in pre- and posttreatment IPSSs and age,
BMI, AHI score, or method of treatment for OSAS
(P > 0.05) (Table 3).
Discussion
Numerous studies have reported that the relationship
between OSAS and erectile dysfunction is
substantial, but there are a limited number of studies
published on the relationship between OSAS and
urinary symptoms. In fact, these studies are related
to nocturia and overactive bladder (4-8). OSAS may
be due to urinary symptoms, as nocturia negatively
affects sleep efficiency. Chartier-Kastler et al. reported
that as the frequency of benign prostate growthrelated nocturia increases, the severity of insomnia
also increases (9). Kemmer et al. studied OSAS cases
categorized as mild, moderate, and severe, and used
patients with upper respiratory resistance syndrome
as controls. They reported that overactive bladder
symptom scores in the patients with moderate and

Table 2. Age, height, weight, and AHI score in the OSAS patients.
Age (years)

Height (cm)

Weight (kg)

AHI

23

23

23

23

Mean

45.57

172.26

91.09

48.830

Standard deviation

10.786

5.754

15.150

32.523

Number

Table 3. The relationship between pre- and post-treatment IPSSs and the characteristics of the patients and treatments.

Difference in pre- and
posttreatment IPSSs

Age (years)

Body mass index (BMI)

Severity of OSAS*

Treatment method

0.49
P > 0.05

0.80
P > 0.05

0.31
P > 0.05

0.35
P > 0.05

*Mild OSAS: n = 4, moderate OSAS: n = 5, and severe OSAS: n = 14.
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present study, lower urinary tract symptoms in OSAS
patients before and after treatment for OSAS were
examined, and the symptoms significantly improved
following appropriate treatment. Guilleminault et al.
reported that the BMI and AHI scores were higher
in OSAS patients with nocturia (6). In the present
study, no statistically significant relationship between

the severity of lower urinary tract system symptoms
in OSAS patients and age, BMI, AHI, or treatment
method was observed.
In conclusion, most of the OSAS patients in the
present study unwittingly had lower urinary tract
symptoms, which significantly improved following
treatment for OSAS.

References
1.

Muller JE, Tofler GH, Stone PH. Circadian variation and
triggers of onset of acute cardiovascular disease. Circulation
1989; 79: 733-43.

7.

Kemmer H. [Sleep apnea in urology. Influence of obstructive
sleep apnea on erection and bladder function]. Urologe A
2009; 48: 1199-202 (article in German).

2.

Krieger J. Clinical presentations of sleep apnoea. European
Respiratory Monograph 1998; 10: 75-105.

8.

Oztura I, Kaynak D, Kaynak HC. Nocturia in sleep-disordered
breathing. Sleep Med 2006; 7: 362-7.

3.

American Academy of Sleep Medicine Task Force. Sleeprelated breathing disorders in adults: recommendations for
syndrome definition and measurement techniques in clinical
research. Sleep 1999; 22: 667-89.

9.

Chartier-Kastler E, Leger D, Montauban V, Comet D, Haab F.
[Impact of nocturia on sleep efficiency in patients with benign
prostatic hypertrophy]. Prog Urol 2009; 19: 333-40 (article in
French).

4.

Kemmer H, Mathes AM, Dilk O, Gröschel A, Grass C, Stöckle
M. Obstructive sleep apnea syndrome is associated with
overactive bladder and urgency incontinence in men. Sleep
2009; 32: 271-5.

10.

Margel D, Shochat T, Getzler O, Livne PM, Pillar G. Continuous
positive airway pressure reduces nocturia in patients with
obstructive sleep apnea. Urology 2006; 67: 974-7.

11.

5.

Moriyama Y, Miwa K, Tanaka H, Fujihiro S, Nishino Y, Deguchi
T. Nocturia in men less than 50 years of age may be associated
with obstructive sleep apnea syndrome. Urology 2008; 71:
1096-8.

Guilleminault C, Lin CM, Gonçalves MA, Ramos E. A
prospective study of nocturia and the quality of life of elderly
patients with obstructive sleep apnea or sleep onset insomnia. J
Psychosom Res 2004; 56: 511-5.

12.

6.

Kemmer H. The relationship between sleep apnea and
overactive bladder. Curr Urol Rep 2009; 10: 448-50.

Hajdug IA, Strollo PJ Jr, Jasani RR. Prevalence and predictors
of nocturia in obstructive sleep apnea-hypopnea syndrome - a
retrospective study. Sleep 2003; 26: 61-4.

622

